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Ciencias Me´dicas, Instituto de Neurobiologı´a, San Juan, Puerto RicoABSTRACT Cardiac cells express more than one isoform of the Na, K-ATPase (NKA), the heteromeric enzyme that creates
the Naþ and Kþ gradients across the plasmalemma. Cardiac isozymes contain one catalytic a-subunit isoform (a1, a2, or a3)
associated with an auxiliary b-subunit isoform (b1 or b2). Past studies using biochemical approaches have revealedminor kinetic
differences between isozymes formed by different a-b isoform combinations; these results make it difficult to understand the
physiological requirement for multiple isoforms. In intact cells, however, NKA enzymes operate in a more complex environment,
which includes a substantial transmembrane potential. We evaluated the voltage dependence of human cardiac NKA isozymes
expressed in Xenopus oocytes, and of native NKA isozymes in rat ventricular myocytes, using normal mammalian physiological
concentrations of Naþo and K
þ
o. We demonstrate that although a1 and a3 pumps are functional at all physiologically relevant
voltages, a2b1 pumps and a2b2 pumps are inhibited by ~75% and ~95%, respectively, at resting membrane potentials, and
only activate appreciably upon depolarization. Furthermore, phospholemman (FXYD1) inhibits pump function without signifi-
cantly altering the pump’s voltage dependence. Our observations provide a simple explanation for the physiological relevance
of the a2 subunit (~20% of total a subunits in rat ventricle): they act as a reserve and are recruited into action for extra pumping
during the long-lasting cardiac action potential, where most of the Naþ entry occurs. This strong voltage dependence of a2
pumps also helps explain how cardiotonic steroids, which block NKA pumps, can be a beneficial treatment for heart failure:
by only inhibiting the a2 pumps, they selectively reduce NKA activity during the cardiac action potential, leading to an increase
in systolic Ca2þ, due to reduced extrusion through the Na/Ca exchanger, without affecting resting Naþ and Ca2þ concentrations.INTRODUCTIONCellular excitability and secondary active transport are
among the many processes driven by the Naþ and Kþ gradi-
ents built by the Na, K-ATPase (NKA or Na/K pump), a
membrane protein that transports three Naþ ions out of
the cell in exchange for importing two Kþ ions at the cost
of the hydrolysis of one ATP molecule (1). NKA is a
P-type IIC ATPase formed by the obligatory association of
a catalytic a subunit, which contains all the machinery for
ion transport and ATP hydrolysis, with an accessory b-sub-
unit, which is essential for membrane targeting and protein
stability (2).
Vertebrates express multiple subunit isoforms with
distinct tissue distributions. There are four a and three b
subunits (reviewed in (3)): a1 is ubiquitous; a2 is present
in all muscle types (4–6), glia (4,7), and neurons (8); a3 is
expressed in neurons (9,10) and in the heart, especially in
the conductive system (11); a4 is present in testis (12).
This article focuses on those isoforms expressed in the heart.
Cardiac cells express b1 and b2 (13) and coimmunoprecipi-Submitted May 29, 2015, and accepted for publication September 10, 2015.
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0006-3495/15/11/1852/11tation experiments showed that b1 associates with a1 and
a2, whereas b2 interacts with a2 and a3 (14). This associ-
ation pattern can be even more intricate as some tissues
express NKA trimers when a member of the single trans-
membrane domain FXYD protein family (isoforms 1
through 7) associates with the axbx dimer. FXYD1 (aka
phospholemman) participates in oxidative- (15) and kinase-
(16) mediated regulation of the cardiac NKA formed by the
a1 and a2 isoforms (17). Thus, mature NKA multimers,
even within a single tissue, exhibit substantial molecular-
level complexity.
A central question that remains unanswered is how the
molecular variety translates into functional diversity?
Several studies that have investigated NKA kinetics show
that the isozymes exhibit relatively small differences in their
affinity for ligands (see (3) for review). In addition, ion
transport by all isoforms is electrogenic and hence affected
by transmembrane voltage (18). Nearly all the voltage
dependence arises from the transit of ions into and out of
their binding sites through access channels (19). In the pres-
ence of both Naþo and K
þ
o most of the voltage dependence
arises from Naþo rebinding to externally facing sites. This
induces voltage-dependent inhibition (VDI) at negative
voltages and a positive slope in the current-voltage relation-
ship (IP-V) (20–23): The larger the [Na
þ]o the stronger thehttp://dx.doi.org/10.1016/j.bpj.2015.09.015
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where the [Kþ]o does not saturate the K
þ binding sites,
competition between Naþ and Kþ is significant and VDI
is even greater than at near-saturating [Kþ]o. Therefore,
the chosen concentrations of Naþ and Kþ can impact trans-
port. The extent of VDI in cardiac cells, due to the individ-
ual sensitivities of the expressed isoforms, is presently
unknown.
The comparison of physiological data from prior reports
is confounded by the fact that, depending on the preparation,
ionic conditions varied, as did the complexity of the under-
lying NKA isoforms. Using batrachian ionic conditions
(%100 mM Naþo), a2-subunits showed greater VDI than
a1 and a3 pumps (24,25), but these experiments failed to
present concrete evidence for the role of voltage in deter-
mining the functional state of the a2 pumps. On the other
hand, studies in cardiac myocytes have either measured
the voltage dependence of all the pumps in the myocyte
(20,26–28), or have measured the activity of a1 and non-
a1 pumps only at 0 mV (29–32).
Here, we present a study of the voltage dependence of
cardiac isozymes under mammalian physiological concen-
trations of Naþo (~150 mM) and K
þ
o (~4.5 mM). Our re-
sults demonstrate that the voltage dependence of pumps
including the a2 isoform is unusually steep over the physi-
ological range. This characteristic suggests that they serve
as a reservoir of pumping activity during the cardiac action
potential but are inactive at ventricular resting potentials. In
addition, we show that association with the b2 subunit exac-
erbates this voltage dependence. Furthermore, although
FXYD1 does not significantly alter the voltage dependence
of the isozymes, it affects the apparent affinity for Kþo,
which in turn depends on the external [Naþ]o. Finally, using
rat cardiac myocytes, where the contribution of different
native isozymes can be distinguished, we demonstrate the
relevance of isoform-specific voltage dependence to cardiac
physiology.MATERIALS AND METHODS
Cell preparation
Oocytes were isolated enzymatically, injected with a mixture of human
axßx cRNA, and maintained for 3–6 days postinjection as described previ-
ously (22).
Rat ventricular myocytes were isolated from 1 to 3 months old rats with
slight modification of methods previously described for Guinea pigs (33).
Briefly, the heart was removed under pentobarbital anesthesia and rapidly
mounted on a Langendo¨rf system and perfused with oxygenated Tyrode
solution consisting of (in mM): 1.8 CaCl2, 145 NaCl, 5 KCl, 1 MgCl2, and
10 HEPES (pH 7.4) at 35C. Once the coronaries were blood-free the heart
was perfused with Ca2þ-free Tyrode for 5 min, followed by application of
Ca2þ-free Tyrode with enzyme solution (1 mg/mL collagenase type 1A
and 0.2 mg/mL protease type XIV (Sigma, St. Louis, MO)) until the
digestion was obvious to sight and tact (~7 min). A solution containing
(in mM): 70 K-glutamate, 25 KCl, 20 taurine, 10 KH2PO4, 1 MgCl2,
0.5 EGTA, 20 glucose, and 10HEPES (pH7.3)was used towash the enzyme,
cut the heart, disperse the myocytes, and store them for up to 36 h at 4C.Molecular biology
Human NKA isoforms were amplified from the neuroblastoma cell line
SHSY5Y cDNA using isoform-specific polymerase chain reaction primers.
Sequences were validated by DNA sequencing and the open reading frames
were subcloned into the Bgl II restriction enzyme site in the pBSTA vector
for oocyte expression (34). Plasmids were linearized with Not I before
in vitro transcription with T7 RNA polymerase. FXYD1, purchased from
the mammalian gene collection (http://mgc.nci.nih.gov) was subcloned
into the pSD5 vector and linearized with Bgl II before transcription
with SP6.Electrophysiology and solutions
Two-electrode voltage-clamp recordings were performed using either an
OC-725C amplifier (Warner Instruments, Hamden, CT) or a CA-1B High
Performance Oocyte Clamp amplifier (Dagan, Minneapolis, MN) in combi-
nation with a Digidata 1440 A/D board, a Minidigi 1A, and pClamp 10 soft-
ware (Molecular Devices, Sunnyvale, CA). Signals were filtered at 2 kHz
and digitized at 10 kHz. Resistance of both microelectrodes (filled with
3 M KCl) was 0.2–0.8 MU. Oocytes were Na-loaded by 20–30 min
incubation in either a solution containing (in mM): 150 HEPES, 20 tetrae-
thylammonium-Cl, and 0.2 EGTA (pH 7.2 with NaOH) or 90 Na-sulfamate,
20 Na-HEPES, 20 TEA-Cl, and 0.2 EGTA (pH 7.2). Both solutions pro-
duced indistinguishable results. The signals from a3 pumps were reduced
with longer than 30-min incubations by a mechanism that was not studied
further. After the 30-min incubation, oocytes were kept in 90 mM Naþ so-
lution until recording. All experiments were performed at room temperature
(RT, 22–24C) except those in Fig. 5 where a TC-10 temperature controller
(Dagan) was used to set the temperature between 24 and 34C.
The 90 mM Naþ solution for two-electrode voltage-clamp (TEVC) was
composed of (in mM): 130 methane sulfonic acid (MS), 90 NaOH, 35
N-methyl D-glucamine (NMG), 10 HEPES, 5 Ba(OH)2, 0.5 Ca(OH)2,
1 Mg(OH)2 (pH 7.6, with NMG, 250–260 mOsm/kg). Temperature-
controlled experiments were performed at 125 mM Naþ (where 35 mM
Naþ was substituted for the NMG of the 90 mM Naþ solution). The
150 mM Naþ solution was used in TEVC and patch-clamp experiments
and contained (in mM): 130 MS, 150 NaOH, 10 HEPES, 5 BaCl2,
1 CdCl2, 1 MgCl2 (pH 7.4, 300–310 mOsm/kg).
A common strategy to completely eliminate contribution of endogenous
pumps to the signals is to introduce ouabain resistance conferring mutations
naturally occurring in the rat a1 subunit (35). However, such strategy pro-
duces significant changes in the affinity for both Naþo and K
þ
o (36).
Because the relevance of our results requires studying wild-type pumps un-
der normal external mammalian solutions, we decided not to introduce any
mutation of this sort. Therefore, to be sure that at least 90% of pump signals
come from the exogenously expressed pumps we only used experiments
that presented >200 nA of Kþ-induced pump current. Small endogenous
pump currents are shown in Fig. S1 in the Supporting Material along
with averages from injected oocytes.
Turnover rates were estimated by dividing the pump current by the total
ouabain-sensitive charge measured in the presence of Naþ without Kþ,
essentially as described by Tavraz et al. (37). To obtain the total charge,
the ouabain-sensitive transient currents when the pulses were turned off
were integrated, the QOFF-V plots were fitted with a Boltzmann distribution
QOFF ¼ Qmin þ Qtot/(1 þ e(V-V1/2)/k), where Qtot is the total charge, Qmin
the charge moved by negative pulses, V1/2 is the center of the distribution,
and k is the slope factor.
Dose response curves from all experiments at each voltage were fitted
globally with the Hill equation I ¼ Imax  ([Kþ]n/([K0.5]n þ [Kþ]n). The
half maximal concentration (K0.5) was shared and the Hill number was
fixed (n ¼ 1.6). In the few cases where unblocking of Kþ-channel currents
(38) at 4.5 or 10 mM Kþ was observed, evident as a second rising phase at
VR 0 mV in the Kþ-induced current versus voltage curve, only ouabain-
sensitive currents were considered.Biophysical Journal 109(9) 1852–1862
1854 Stanley et al.Whole-cell patch-clamp recording of rat ventricular myocytes was per-
formed with an Axopatch 200A, a Digidata 1322 A/D board, and pClamp
10 software (all from Molecular Devices), with acquisition at 10 kHz,
filtered at 2 kHz. Pipettes had resistances between 1 and 3 MU when filled
with intracellular solution containing (in mM): 130 L-glutamic acid, 10
HEPES, 10 EGTA, 10 tetraethylammonium-Cl, 5 MgATP, 1 MgCl2, and
85 NaOH, pH 7.4 with CsOH (~65 mM). The 150 mM external solution
was heated to 35C with an in-line heater connected to a temperature
controller TC344B (Warner Instruments).
Kþ was added from a 450 mM K-MS stock. Bath electrodes were AgCl
pellets connected by 3 M KCl agar bridges. NKA-mediated current was
identified by inhibition with ouabain at concentrations of 200 mM in oo-
cytes, and 5 mM for non-a1 pumps or 5 mM ouabain for a1 pumps in rat
ventricular myocytes.Western blotting
Membranes from ventricular tissue were prepared as described by Fuller,
et al. (39). Protein electrophoresis was performed using Mini-Protean Tgx
gels 7.5% (BioRad, Hercules CA) in Mini Protean Tetra System (BioRad).
Protein was transferred onto 0.22 mm polyvinylidene fluoride membrane
using Hoefer TE77. Transferred membranes were blocked with Tris-Buff-
ered Saline (TBS) supplemented with 5% milk and Tween 20 (TBST) for
1 h, incubated overnight with TBS supplemented with 1% milk, 1% bovine
serum albumin (BSA) and containing the TEDprimary antibody (40) diluted
1:100 (generous gift of Thomas A. Pressley, TTUHSC) followed by 1 h in
TBST supplemented with 1%milk, 1% BSA and containing the horseradish
peroxidase antirabbit (1:1000 dilution). Imaging was performed at the
TTUHSC Molecular Biology Core Facility with Luminol (Santa Cruz
Biotechnology, Dallas, TX) on an ImageQuant LAS 4000 (GE Healthcare,
Pitsburgh, PA).Immunofluorescence
After isolation cells were allowed to attach to poly-L-lysine-coated cover-
glass, fixed with paraformaldehyde for 15 min at RT, washed, permeabi-
lized with triton X-100 for 10 min at RT, washed with phosphateBiophysical Journal 109(9) 1852–1862buffered saline (PBS), and blocked in PBS supplemented with 3%
BSA for 1 h. Samples were then incubated with primary antibody (PBS
supplemented with 1% BSA) overnight, washed, and incubated with
secondary antibody (PBS supplemented with 1% BSA) for 1 h. Permeabi-
lized cells, blocked and treated only with secondary antibody were used
as controls in each myocyte preparation (not shown). Images were ac-
quired at the TTUHSC Image Analysis Core Facility on a Nikon Ti-E
microscope.RESULTS
Function of human NKA isozymes in Xenopus
oocytes with mammalian osmolality
As mentioned above, all previous characterizations of NKA
function in oocytes were made at 80–100 mM Naþo, with
variable Kþo concentrations (24,25). We first evaluated
whether these batrachian ionic conditions might have led
to an underestimation of the level of VDI observed at nega-
tive voltages with some isoforms, particularly a2 pumps.
TEVC was used to address the effect of switching from
90 mM Naþo to 150 mM Na
þ
o on the voltage dependence
of the current induced by 4.5 mM Kþo, the normal mamma-
lian serum Kþo concentration (Figs. 1 and 2).
Fig. 1 A shows a representative current recorded on a slow
time base, from an oocyte expressing a2b1 pumps held
at 50 mV. The application of 4.5 mM Kþo induced out-
ward currents in both 90 mM and 150 mM external Naþ.
Sharp vertical deflections in the continuous trace correspond
to the application of brief (100 ms) voltage pulses. The cur-
rent at the end of those pulses is plotted as a function of
voltage in Fig. 1 B. Measurements in the absence of Kþ at
the times marked a, c, and e in Fig. 1 Awere then subtractedFIGURE 1 TEVC recording of a Xenopus
oocyte 5 days after injection with human a2b1
cRNAs. (A) Continuous recording at 50 mV.
Application of a 4.5 mM Kþ-induced outward
pump current (IP) in 90 as well as in 150 mM
Naþ (note significantly smaller current at
150 mM Naþ). 100 mM ouabain was applied after
the 10-min break inhibiting Kþ-induced IP. Sharp
vertical deflections correspond to 100 ms pulses
used to obtain the current versus voltage (I-V) re-
lationships. (B) I-V curves obtained at the times
indicated by small cap letters in (A). (C) Voltage
dependence of 4.5 mM Kþ-induced currents at
90 mM Naþ, 150 mM Naþ, and 150 mM Naþ
with ouabain. Note the stronger VDI at 150 mM
Naþ. To see this figure in color, go online.
FIGURE 2 Voltage dependencies of all four cardiac isoforms at 4.5 mM
Kþ. (A) Voltage dependence of 4.5 mM Kþ-induced IP normalized to the
value at þ40 mV in 90 mM Naþ to illustrate the effect of 150 mm Naþ,
for a1b1 (squares, n ¼ 7), a2b1 (circles, n ¼ 7), a2b2 (triangles,
n ¼ 16), and a3b2 (stars, n ¼ 9). (B) Turnover rate (T/O), for a1b1 n ¼
11; a2b1 n ¼ 8; a2b2 n ¼ 8; and a3b2 n ¼ 6. To see this figure in color,
go online.
Cardiac Na/K Pump Isozymes 1855from those marked b, d, and f, to obtain the Kþ-induced cur-
rents plotted in Fig. 1 C. Thus, Fig. 1 C displays the Kþ-
induced currents with 90 mM or 150 mM Naþo in the
absence of ouabain and in 150 mM Naþo after inhibition
with 100 mM ouabain. Lack of current after ouabain demon-
strates that Kþo-induced current (IP) is due to the Na/K
pump. The activity of a2b1 pumps expressed in this oocyte
is highly dependent on voltage within the physiological
voltage range; from 90 mV to þ40 mV.
We performed similar experiments on oocytes expressing
human a1b1, a2b1, a2b2, and a3b2 pumps because evi-
dence suggests that these isoforms are present, and interact,
in rat and guinea pig ventricular myocytes (14). Fig. 2 A
plots the Kþ-induced currents in 150 mM Naþo normalizedto the same currents induced in 90 mM Naþo at þ40 mV. To
minimize the contribution of endogenous IP to the signals
(~25 nA, Fig. S1) we limit our analysis to oocytes showing
currents R200 nA at our normalization point. It is evident
that switching from 90 to 150 mM Naþo induces a strong
current reduction in Na/K pumps created by all cardiac iso-
form combinations (a1b1, a2b1, a2b2, and a3b2) and this
effect is present over the entire range of physiological mem-
brane potentials. Furthermore, 150 mM Naþ induces a dra-
matic IP reduction for all a2-containing pumps at negative
voltages. Endogenous pumps are responsible for most of
the IP remaining at 80 mV in a2b2 expressing oocytes
(cf. Fig. S1, gray hexagons).
The inhibitory effect of 150 mM Naþo can be better
appreciated when the data is presented as turnover rate
(Fig. 2 B). To obtain the turnover rate (T/O) under physio-
logical conditions, one must estimate the number of pumps
in each oocyte, and this was accomplished by measuring
the total charge (Qtot) moved by NKAs in the absence of
Kþ (37). To be thorough, we also studied the function of
a1b2 and a3b1 pumps. The association of any a-subunit
with b2 shifts their voltage dependence toward positive
voltages (Fig. S2).
To better understand how hypo- and hyperkalemia could
affect cardiac pumps under physiological Naþ, we investi-
gated the dose dependence for Kþo activation in 150 mM
Naþo (Fig. 3). A continuous current record from an oocyte
expressing a1b1 being held at 50 mV is shown in
Fig. 3 A as an illustration of our experimental design. Kþ
induces current in a concentration-dependent manner
and saturates at ~10 mM. Fig. 3 B displays the Kþ-induced
currents as a function of voltage. Fig. 3 C shows the
current as a function of the Kþ concentration at twoFIGURE 3 Dose response for Kþ in an a1b1 ex-
pressing oocyte. (A) Continuous recording four
days after injection. Step changes in [Kþ] produced
a concentration-dependent increase in outward
current. (B) Voltage dependence of Kþ-induced
ouabain-sensitive currents at different [Kþ].
(C) The IP at different voltages were plotted against
[Kþ] and fitted with a Hill equation (line plots).
Only two voltages are shown for clarity. The K0.5
and the maximal turnover (Imax/Qtot) are plotted
as a function of voltage in Fig. 4. To see this figure
in color, go online.
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FIGURE 5 (A) Continuous trace at 50 mV (top) and IP-V curves (bot-
tom) from an oocyte expressing a2b2 pumps bathed by 125 mM Naþo in
which the T was increased from 24C to 34C. The small caps indicate
when the current-voltage relationships shown subtracted in the IP-V curves
obtained. (B) Turnover rate as a function of V for a2b1, a2b2, and unin-
jected oocytes (average of four oocytes each with measurements at both
T). To account for rundown, the IP at each Twas divided by the total charge
at the same T. For example, in (A) the Q-V at 24C was obtained by sub-
tracting the traces in a minus the traces in f, and that at 34C by subtracting
traces in e minus traces in f. Rundown, was present in nearly all experi-
ments. For injected oocytes, only those with currents R200 nA at 0 mV
at both T, and without significant changes in linear capacitance (obvious
in the transient currents and in Q-V curves) were included in (B). To see
this figure in color, go online.
1856 Stanley et al.voltages, where the continuous lines are fits of the Hill equa-
tion to the data.
The voltage dependence of the Hill equation parameters
fitted to the data from all cardiac isoforms combinations
are presented in Fig. 4. The K0.5 for K
þ
o and the maximal
turnover rates (T/Omax) as a function of transmembrane
voltage are shown in Fig. 4, A and B, respectively. It must
be noted that a2b2 pumps have an extremely low apparent
affinity for Kþo, especially at negative voltages (K0.5 R
10 mM at 60 mV); because of this strong voltage depen-
dence neither the K0.5 nor the Imax can be accurately deter-
mined below 60 mV. To extend our analysis beyond the
cardiac isoforms combinations, we studied a1b2 and a3b1
(Fig. S3). The a1b2 isozyme has a lower affinity for Kþ
than a1b1, but only at negative potentials.
The question arises of whether the lower than physiolog-
ical temperature (T) used for the previous experiments (22–
24C) could have affected the NKA’s voltage dependence.
We measured the voltage dependence of pump function at
24C and 34C (Fig. 5), but with 125 mM Naþ (oocytes
could not withstand 150 mM Naþ at high T). The top trace
in Fig. 5 A shows a continuous recording at 50 mV (inter-
rupted by 100 ms-long voltage pulses responsible for the
sharp vertical deflections at this slow time base) from an
oocyte injected with a2b2. The IP-V curve in the same
oocyte is shown at the bottom. Fig. 5 B illustrates the
mean turnover rate at each T measured in uninjected oocytes
(uninj., gray hexagons) and in oocytes injected with a2b1
(circles), or a2b2 (triangles). Both, the lack of a strong
effect on voltage dependence and the 2.5-fold change in
NKA turnover rate, are consistent with previous electro-
physiological studies addressing the effect of T on pump
function (41–43).FIGURE 4 Voltage dependence of apparent affinity for Kþ and
maximum turnover rate. (A) K0.5 as a function of voltage at 150 mM
Naþ. a1b1 (squares, n ¼ 4), a2b1 (circles, n ¼ 3), a2b2 (triangle,
n ¼ 6), a3b2 (stars, n ¼ 3). (B) Maximum turnover rate (Imax/Qtot) as a
function of voltage. The Imax measured in the same experiments
at þ40 mV averaged 332 571 nA (a1b1), 251 524 nA (a2b1),
599 569 nA (a2b2), and 338 581 nA (a3b2). Note uncertainty of K0.5
for a2b2 at V % 60 mV due to unreliable measurements for a2b2 at
very negative potentials because of small endogenous pump signals (c.f.
Fig. S1). To see this figure in color, go online.
Biophysical Journal 109(9) 1852–1862The striking difference in voltage dependence among the
human isoforms carries profound physiological implica-
tions. We tested whether the differences in VDI that we
measured in oocytes can also be observed in native rat ven-
tricular myocytes (Fig. 6). In rodents the a1 subunit has a
relatively low affinity for ouabain (IC50 ~100 mM), whereas
a2 and a3 pumps are far more sensitive (IC50< 1 mM) (44).
Thus, the function of the a1 isoform can be readily sepa-
rated from a2 and a3 using different ouabain concentrations
(5 mM and 5 mM).
Fig. 6 A shows a continuous recording from a ventricular
myocyte bathed by 145 mM Naþo held at 40 mV. Perfu-
sion of 4.5 mM Kþo activated outward IP, which was in-
hibited by different ouabain concentrations. Application of
5 mM ouabain inhibited the current due to non-a1 pumps
and 5 mM ouabain inhibited all isoforms. Although a small
rundown of the current cannot be ruled out, it is clear that
only a1 pumps recover significantly after washout, due to
the faster ouabain unbinding from this isoform; the unbind-
ing time constant at 37C is ~4 min for a2 pumps and
~100 min for a3 pumps (45). The current from a1 pumps
is obtained by subtracting the current in 5 mM ouabain
from that in 5 mM ouabain. The component from non-a1
pumps is obtained by subtracting the current in 5 mM
ouabain from that without ouabain. The IP-V curves
measured at the end of 100-ms step pulses ( ¼ a1;
D ¼ a2 þ a3) are shown in Fig. 6, B and C. The non-a1
FIGURE 6 Voltage dependence of NKA isoforms in rat cardiac myo-
cytes. (A) Current from a myocyte bathed by 145 mM Naþ at 40 mV.
Kþ application (4.5 mM) activates outward IP, which was inhibited by a
subsequent addition of ouabain; 5 mM inhibited non-a1 (a2 þ a3) and
5 mM inhibited all isoforms. (B) IP-V curve for the a1 and non-a1 pumps.
IP/cell capacitance accounts for myocyte size variation. (C) IP-V curve for
both components normalized to 0 mV. 85 mM Naþi, 5 mM MgATP,
T ¼ 35C (n ¼ 4, from three different animals aged 7, 8, and 16 weeks).
To see this figure in color, go online.
FIGURE 7 NKA catalytic subunit isoforms in ventricular myocytes.
(A) Isolated myocytes stained against a1 (red) and a2 (green). Nuclei
were stained with DAPI (blue). (B) Another representative myocyte stained
against a3 (red) and a2 (green). (C) Western blot showing the ladder (left
lane), boiled left ventricle membrane preparation (middle lane), and 65C
treated membrane preparation (right lane) probed with rabbit polyclonal
antibody against a3 (TED).
Cardiac Na/K Pump Isozymes 1857component (a2 þ a3) is ~20% of the total, consistent with
previous reports at RT with similar ionic conditions (30).
Fig. 6 C displays a1 and non-a1 components normalized
to the current at 0 mV. Note that the stronger voltage depen-
dence of the non-a1 component is consistent with a greater
abundance of a2 pumps than a3 pumps in adult rat myo-
cytes (46).
We tested whether the incomplete inhibition by voltage of
the non-a1 component could be explained by a small per-
centage of a3 pumps, whose presence in adult rat hearts is
still under debate. Coimmunostaining of ventricular myo-
cytes with a monoclonal a1 antibody (a1-C464.6, Santa
Cruz Biotech) and a rabbit-raised polyclonal a2 antibody
(HERED (40)) always produced the same staining pattern
(Fig. 7 A): a2 pumps appear mainly confined to T-tubules,
whereas a1 pumps are present everywhere, consistent
with previous functional (30) and immunostaining reports
(14,47). We observed even a3 staining of the nontubular
membrane with a monoclonal commercial a3 antibody
(XVIF9-G10, Santa Cruz Biotech, Fig. 7 B). Immunostain-
ing with this antibody produced identical results in all my-
ocytes isolated from 11 adult animals (aged 3 weeks to 1
year). To confirm the presence of a3, we also performed
Western blots with a rabbit polyclonal antibody (TED
(40)). Some (e.g., Fig. 7 C), but not all, heart preparations
showed a clear a3 band, consistent with previously reported
animal-to-animal variation (11).
In the heart, transient modulation of NKA function by ki-
nase-dependent phosphorylation is mediated by FXYD1(48,49). It has been shown that dephosphorylated FXYD1
interacts with a1 and a2 pumps (16) and reduces their activ-
ity by lowering the apparent affinity for intracellular Naþ
and for extracellular Kþ (16,29,50,51). To ensure that
FXYD1 was not phosphorylated by the variable and rela-
tively high basal protein kinase A (PKA) activity in oocytes
(52), we injected a PKA inhibitor peptide (PKI) 2 h before
recording. PKI injection had no effect on the functional pa-
rameters of the three isozymes in the absence of FXYD1
(for clarity, only the results of the control with PKI-injected
a1b1 pumps are shown in Fig. 8).
We tested whether switching from 90 mM to 150 mM
Naþ had a distinct effect on a1b1, a2b1, and a2b2 pumps
interacting with FXYD1 (Fig. 8). Fig. 8 A shows the current
induced by 4.5 mM Kþ in 150 mM Naþ, normalized to the
current in 90 mM Naþ at þ40 mV (as in Fig. 2 A). For all
three isoform combinations, FXYD1 causes a more pro-
nounced reduction in pump current by switching to
150 mM Naþ, but this effect appears to be voltage indepen-
dent. Fig. 8 B shows that pumps associated with FXYD1
have a reduced apparent affinity for Kþo. Thus, Na
þ
o is aBiophysical Journal 109(9) 1852–1862
FIGURE 8 Effect of FXYD1 on a1 and a2 isozymes. (A) Voltage
dependence of 4.5 mM Kþ-induced IP at 150 mM Na
þ normalized to the
signal measured at þ40 mV in 90 mM Naþ. (B) K0.5 for Kþ activation as
a function of voltage obtained in dose response experiments. Note that
the K0.5 for all pumps is increased by FXYD1. All FXYD1 experiments
were performed after injection of PKI; no significant effect after PKI
injection was observed for a1b1 (gray squares), a2b1 or a2b2 (PKI
injected a2 pumps were excluded for clarity). To see this figure in color,
go online.
1858 Stanley et al.more effective competitor for Kþo and more potently re-
duces pump current. The fold change in Kþo affinity
induced by FXYD1 that we report here, however, is
significantly larger than that in previous reports in oocytes
(16,17).DISCUSSION
Our data provide conclusive evidence that the difference in
the voltage dependence between the two main cardiac mus-
cle NKA catalytic subunit isoforms is dramatic and relevant
for ion homeostasis in myocytes. Furthermore, we demon-
strate that the b1 and b2 subunits are important regulators
of kinetics and this allows us to hypothesize a mechanism
underlying kinetic differences observed between different
preparations in previous reports, including significant differ-
ences on the magnitude of the inhibitory effects of FXYD1.
These findings and their implications for the beneficial ac-
tion of cardiotonic steroids in heart failure will be discussed
next.Which pump isozymes and isoforms are present
in the heart?
The presence of a1, a2, b1, and b2 is well accepted in ven-
tricular myocytes of several mammalian species (11). The
a3 isoform has also been reported in human ventricle, and
reports have also shown that it is abundant in neonatal ani-
mals, but the amount diminishes as the animals approach
adulthood (46). In this report, we present data that shows
that there is a very small fraction of a3 pumps in adult rat
myocytes: immunostaining with a3 antibodies (Fig. 7 B),
Western blots showing detection in membrane preparationsBiophysical Journal 109(9) 1852–1862from some animals, but not all (Fig. 7 C), and pump current
versus voltage plots where a small amount of non-a1
component resists VDI at100 mV (Fig. 6, B and C). These
observations are fully consistent with a previous report us-
ing Western blots that showed variable a3 presence in adult
rats (11).
There are many possible combinations for functional
pumps because all the axbx form functional pumps
in vitro (24). Nevertheless, studies in brain (53) and heart
(14) indicate that a1 does not associate with b2. Further-
more, Madin-Darby canine kidney cells expressing the a1,
b1, and b2 show a clear preference to form the a1b1
isozyme (53) indicating that a1b2 is not physiologically
relevant. How much of the ventricular a2 component may
be formed by b2 isoforms? Because the K0.5 for K
þ
o for
a2b2 pumps in oocytes at mammalian physiological con-
centrations (Fig. 4 B, ~10 mM at 20 mV) is much higher
than the K0.5 values previously reported in myocytes for
non-a1 pumps (29) we think that most a2 pumps in ventric-
ular myocytes must be associated with b1 with a low expres-
sion level of b2, as previously suggested (13).Functional characteristics of different isozymes
in mammalian solutions
Several studies have investigated the kinetic differences be-
tween NKA isozymes, both biochemically and electrophys-
iologically. When coexpressed with b1, the affinity for Naþi
is highest in a2, intermediate in a1, and lowest in a3 sub-
units (54,55). All a subunits presented similar apparent af-
finities for Kþo when measurements were taken without
Naþo. However, the affinities for K
þ
o differed in the pres-
ence of 100 mM Naþo, where the lower affinity for K
þ
o cor-
responds to the pump with the highest Naþ affinity (a2) and
the highest apparent affinity for Kþo, to the catalytic subunit
with lowest Naþ affinity (a3) (25). In other words, because
external Naþ competes with Kþ for the ion-binding sites,
the pump’s apparent affinity for Kþo is highly dependent
on the concentration of Naþ.
Our experiments highlight the importance of the actual
Naþo concentration when trying to understand the physio-
logical role of specific pumps. Indeed, we measured signif-
icantly (~2- to 3-fold) lower apparent affinities for Kþ at
mammalian Naþ concentrations than those previously re-
ported for mammalian pump isoforms expressed in Xenopus
oocytes (24,25,37,56,57). For instance, Larsen et al. (57) re-
ported that the K0.5 for K
þ of a2b2, at 100 mV with
70 mM Naþ, was ~7 mM, although we estimate that it is
on the order of 15 mM with 150 mM Naþ (based on extrap-
olation). We think that due to the lower Naþ concentration
used in previous reports the physiologically significant
lower affinity for a2b1 pumps at negative voltages could
not be observed. It is also possible that the use of
ouabain-resistant pumps with altered function masked this
observation.
Cardiac Na/K Pump Isozymes 1859The turnover rates we calculated are comparable to those
previously measured in oocytes at RT. For example, the
turnover rate of human a2b1 pumps at 30 mV, 90 mM
Naþ, and 10 mM Kþ reported by Tavraz et al. (37) was
13 s1 nearly identical to the values we observe: 14 s1
at 20 mV and 11 s1 at 40 mV. Crambert et al. (24) re-
ported the maximum turnover rate for all nine wild-type hu-
man isoforms at 50 mVand 90 mM Naþ to be ~30 s1 for
a1b1 and a1b2; ~22 s1 for a2b1 and a2b2; and ~10 s1
for a3b1 and a3b2. At 40 mV and 150 mM Naþ we
report 19.5 5 2.5 s1 for a1b1, 7.2 5 0.4 s1 for
a1b2, 11.2 5 1.2 s1 for a2b1, 4.1 5 0.4 s1 for a2b2,
18.5 5 1.3 s1 for a3b1, and 12.8 5 1.1 s1 for a3b2.
The slightly lower turnover rates we report here for a1
and a2 pumps could be accounted for by the difference in
ionic composition as Crambert et al. used 80 mM Naþ
with nearly saturating 10 mM Kþ.Voltage dependence of cardiac NKA isozymes at
physiological NaD concentrations: the role of a2
pumps and the b2 subunit
All pumps are subject to inhibition at negative potentials.
This VDI depends on the concentration of external Naþ.
The pump-current versus voltage curves shift to the right as
the Naþ concentration (20), or the Naþ affinity of the sites
in the pump is increased, but it shifts to the left as the concen-
tration of Kþ (as a competitor for Naþ) is increased. Thus, the
physiologic relevance of this process must be assessed at
normal Naþo and K
þ
o concentrations. Our results (Fig. 2)
show that at physiological Naþo and K
þ
o, a2 pumps, when
associated with b1, are ~75% inhibited at membrane poten-
tials corresponding to the resting potentials in ventricular
myocytes (~75 mV (58)). When they associate with the
b2 subunit, they are ~95% inhibited (percentages obtained
after subtraction of endogenous currents, c.f. Fig. S1). We
confirmed the stronger voltage dependence of a2-pumps
(~70%of non-a1 pumps) in ratmyocytes (Fig. 5). Our results
strongly suggest heart a2 pumps are not meant to pump
continuously. This is in contrast to thea1 pumps that perform
a housekeeping role. Based on our data, we propose that a2
pumps are inhibited at the resting membrane potential and
do not significantly contribute to Naþ pumping (nor to
Ca2þ handling). During the cardiac action potential they
are highly active when there is a need for increased Naþ
extrusion due to the large Naþ influx through Naþ channels
and to the inversion of the Na/Ca exchanger (NCX) function
due to the depolarized membrane potential.
It is therefore expected that this safety net function of the
a2 NKA also occurs in other tissues where it is highly ex-
pressed. For instance, a2 pumps constitute >70% of the
pumps in skeletal muscle, being principally targeted to the
T-tubules (59) where it must associate with b1 and b2 sub-
units (60). In this muscle type the resting potentials can be
as low as 90 mV, meaning a2 pumps will be completelyinactive, consistent with the minimal effect of NKA a2 in-
hibition in the skeletal muscle resting potential (61).
Although the skeletal muscle action potentials are very
brief, a train of activity produces accumulation of Kþ in
the T-tubule leading to a transient depolarization. This com-
bination of elevated Kþo and depolarization would activate
a2 pumps to clear Kþo from the tubule. Consistent with this
idea, a recent report by Di Franco et al. (62) showed a
reduced apparent affinity for Kþ for a2, compared to a1
pumps, in mouse skeletal muscle fibers.
Previous reports have indicated that b subunits have rela-
tively minor consequences on NKA kinetics (24,63,64). Our
results contradict this idea.We show that compared to b1 iso-
zymes,b2 isozymes induce drastic changes in pump function,
significantly shifting the IP-voltage curve toward depolarized
potentials due to an increased affinity for Naþo. Within the
physiologic voltage range, the effect is most pronounced
when associated with a2, as a2b2 pumps are>80% inhibited
below 60 mV due to the very low affinity for Kþ at this
voltage (Fig. 4 A). This suggests that b2 association with a2
is important to ensure that these pumps will activate only
when there is a need to clear elevated external Kþ. It is easy
to envision how a mix of a2b1 and a2b2 can contribute
when there is a need to clear different amounts of Kþo accu-
mulation. Larsen et al. (57) suggested a similar mechanism
in glia, where the depolarization induced by the increase in
Kþo produces activation of the a2b2 pumps when they are
needed to clearKþ from the extracellular space afterKþo con-
centration increases following a train of action potentials or
injury. Our results reinforce their proposal and show that dif-
ferential interaction of a2 with b1 and b2 may provide two
safety net pumps with different Kþo affinities.NKA a2 pumps, NCX, and the action of digitalis
Cardiotonic steroids (aka digitalis), such as ouabain and
digoxin, are specific inhibitors of the NKA that have been
used to treat heart failure since the 18th century (65). Cardio-
tonic steroids’ therapeutic action occurs through NKA inhi-
bition as the decrease in Naþ electrochemical gradient
reduces Ca2þ extrusion via NCX (66). This in turn leads to
a higher Ca2þ load within the sarcoplasmic reticulum, thus
allowing a larger Ca2þ release during the systole (67). Recent
reports indicate that human a2 pumps have a slightly higher
affinity for the clinically preferred cardiotonic steroids than
a1 pumps (68). It is widely believed that the actions of
cardiotonic steroids on cardiac contraction are mediated
through the a2 subunit, which occurs at a higher density in
the T-tubules ((31) and Fig. 6 A). Although both a1 and a2
interact with NCX (69,70), a2 and NCX interact within
membrane micro-domains (71,72), and it was also shown
that a2 preferentially modulates Ca2þ transients (73,74).
The results described previously have led to the idea
that by targeting the differentially expressed a2 subunit,
cardiotonic steroids could increase Ca2þi and contractionBiophysical Journal 109(9) 1852–1862
1860 Stanley et al.force by binding preferentially to only ~25% of the total
pumps, which account for up to 50% of the pumps in the
T-tubules (31). Another reason why binding to a2 mediates
the beneficial effects of cardiotonic steroids comes from
their strong VDI; as a2 pumps are inactive at resting poten-
tials, their inhibition would not affect the Ca2þ extrusion
capacity at rest, but it would affect [Ca2þ] handling during
systole. The change in driving force due to inhibition of
50% of the tubular pumps may favor backward Ca2þ trans-
port by NCX, also increasing systolic Ca2þ.
Hypokalemia, a pathophysiologic condition that in-
creases the risk of ventricular arrhythmias, is another condi-
tion where the lower Kþ-affinity and stronger VDI of a2
pumps appears to play an important role. It has been
recently shown that hypokalemia hyperpolarizes rat ventric-
ular myocytes and reduces the non-a1 pumping component,
leading to larger Ca2þ transients with negligible changes in
basal Ca2þ (cf. Figs. 1 and 2 in (74)) as we propose thera-
peutic concentrations of digitalis do.The inhibitory effect of FXYD1
It has been shown that FXYD1 interacts with the a1 and a2
isoforms, but not with the a3 isoform (17), leading to partial
inhibition of NKA. Fo¨rster resonance energy transfer exper-
iments suggest that the relief of this inhibition through phos-
phorylation of FXYD1 by PKA and protein kinase C
involves a separation of FXYD1 and a subunit at the intra-
cellular ends of their transmembrane segments (51). The in-
hibition by FXYD1 at saturating Naþi reflects, at least in
part, a reduction of the NKA’s affinity for Kþo. According
to previous reports, FXYD1 induced a smaller increase in
the K0.5 for K
þ
o in oocytes at 90 mM Na
þ
o (~40%, 17)
than in transgenic mice at 120 mM Naþo (~100%, 29).
This difference brought into question the physiologic rele-
vance of oocyte experiments.
Our results demonstrate that human FXYD1 induces
physiologically relevant changes in apparent affinity for
Kþo of human ab isozymes, and again, quantitatively recon-
cile data obtained in different systems. In better agreement
with the mice myocytes experiments, at 20 mV and
150 mM Naþo, the K0.5 without and with FXYD1 varied,
respectively, from 1.3 mM to 2.9 mM for a1b1 and from
2.5 to 3.7 for a2b1. Both the injection of PKI to inhibit
all basal PKA activity and the use of mammalian [Naþ]o
may have contributed to the observed differences. Finally,
the finding that dephosphorylated FXYD1 does not affect
the voltage dependence (neither the position of the IP-V
curve nor that of the K0.5-V curve shift with respect
to voltage) indicates that FXYD1 inhibition affects a
completely different pathway. The larger inhibitory effect
of 150 mM Naþo at 4.5 mM K
þ
o may simply reflect the
increased binding of Naþo secondary to the reduction in
Kþo affinity. A small increase in Na
þ binding affinity, how-
ever, cannot be ruled out by our experiments.Biophysical Journal 109(9) 1852–1862CONCLUSION
This work demonstrates a previously unnoted relevance for
the NKA isozyme-specific voltage dependence. In partic-
ular, their voltage dependence allows a2 pumps to act as a
safety net which, in the heart, will only increase Naþ extru-
sion upon depolarization during an action potential. In this
context, inhibition of a2 pumps with cardiotonic steroids
should only increase intracellular Naþ levels (and thus intra-
cellular [Ca2þ]) during depolarization (controlled by a2 and
a1 pumps), but not at rest (dependent on a1 pumps). On the
other hand, although voltage dependence is apparently irrel-
evant for FXYD1-mediated regulation, future studies will
test the possibility of voltage dependence being an impor-
tant regulatory step for NKA function, as a small shift in
the current voltage curve, particularly for a2 pumps, could
have highly relevant consequences for pumping capacity.SUPPORTING MATERIAL
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